Aeries Technology Achieves Great Place To Work(R) Certification for Third Consecutive Year

Aeries Technology Achieves Great Place To Work(R) Certification for Third Consecutive Year Recognition Underscores Commitment to Building High-Performance, Engaged Workforce. GlobeNewswire January 12, 2026 NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — Aeries Technology, a global leader in AI-enabled value creation, business transformation, and Global Capability Center (GCC) delivery for private equity (PE) portfolio companies, […]

Alliance Entertainment Named Exclusive Physical Media Distribution Partner for Amazon MGM Studios in North America

Alliance Entertainment Named Exclusive Physical Media Distribution Partner for Amazon MGM Studios in North America Deal strengthens Alliance's leadership in premium home entertainment distribution across major franchises and catalog titles GlobeNewswire January 12, 2026 PLANTATION, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a premier distributor and omnichannel fulfillment partner

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones GlobeNewswire January 12, 2026 Limited Market Release (LMR) of the LIBERTY(R) System is on Schedule Building on Positive Customer Feedback and Growing Market Enthusiasm, the Company Prepares for Full Market Release (FMR) in Q2 HINGHAM, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) — Microbot Medical Inc.

Draganfly to Present at 28th Annual Needham Growth Conference, January 14, 2026

Draganfly to Present at 28th Annual Needham Growth Conference, January 14, 2026 GlobeNewswire January 12, 2026 Tampa, FL, Jan. 12, 2026 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading developer of drone solutions and systems, today announced that Chief Executive Officer, Cameron Chell, will deliver

NANO Nuclear Signs Memorandum of Understanding with Ameresco to Explore the Deployment of Advanced Microreactor Technologies on Federal and Commercial Sites

NANO Nuclear Signs Memorandum of Understanding with Ameresco to Explore the Deployment of Advanced Microreactor Technologies on Federal and Commercial Sites GlobeNewswire January 12, 2026 New York, NY and Framingham, MA, Jan. 12, 2026 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor

Gaia Launches First Personalized AI Guides for Spiritual Transformation, Surpassing 2 Million Prompts in 60 Days

Gaia Launches First Personalized AI Guides for Spiritual Transformation, Surpassing 2 Million Prompts in 60 Days Strong Early Adoption Signals Enhanced Member Engagement and Retention, Supporting Long-Term Value Creation GlobeNewswire January 12, 2026 BOULDER, Colo., Jan. 12, 2026 (GLOBE NEWSWIRE) — Gaia (NASDAQ: GAIA), the world's largest conscious streaming platform with 10,000 videos dedicated to

Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook

Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook GlobeNewswire January 12, 2026 New name reflects the Company's strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature gene-editing capabilities Pre-IND meeting held in 4Q 2025 following MGX-001 preclinical data demonstrating curative FVIII activity

Eagle Energy Metals Engages BBA USA Inc. to Help Advance Aurora Toward Pre-Feasibility

Eagle Energy Metals Engages BBA USA Inc. to Help Advance Aurora Toward Pre-Feasibility Targeted Drill Program Aimed at Advancing Aurora Uranium Project as Company Progresses Toward Planned Nasdaq Listing GlobeNewswire January 12, 2026 RENO, Nev., Jan. 12, 2026 (GLOBE NEWSWIRE) — Eagle Energy Metals Corp. (“Eagle” or the “Company”), a next-generation nuclear energy company with

Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting

Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting GlobeNewswire January 12, 2026 The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts demonstrate that modest (~10%) NfL reductions are significantly associated with lower mortality risk,

ORIC(R) Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones

ORIC(R) Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones GlobeNewswire January 12, 2026 Announced rinzimetostat (ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with AR inhibitors Presented potential best-in-class enozertinib Phase 1b data demonstrating highly competitive systemic

Scroll to Top